
|Videos|September 10, 2021
Comparing suitable naïve versus pre-treated DME patients
Author(s)OT Staff Reports
Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Advertisement
Javier Zarranz-Ventura MD, PhD, FEBO, a vitreoretinal consultant at
Institut Clínic de Oftalmologia (ICOF), Hospital Clínic de Barcelona andInstitut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS), discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
October 2026 retina recap: Duravyu stumbles, DAYBREAK delivers, and optogenetics takes the Nobel
3
Training refractive surgeons and expanding access to eye surgery
4
Distinguishing Lambert-Eaton myasthenic syndrome from ocular myasthenia gravis in the eye clinic
5















